Additional Information for Coccidioidomycosis (Valley Fever)
MMWR Articles:
Summary of Notifiable Diseases--- United States, 2009. MMWR Weekly, May 13, 2011/58(53);1-100.
Increase in Coccidioidomycosis --- Arizona, 1998--2001 MMWR Weekly February 14, 2003/52(06);109-112
Coccidioidomycosis -- Arizona, 1990-1995. MMWR Weekly, December 13, 1996/45(49);1069-1073.
Coccidioidomycosis -- California, 1991-1993. MMWR Weekly, June 17, 1994/43(23);421-423.
Publications:
Engelthaler DM, Chiller T, Schupp JA, et al. Next-generation sequencing of Coccidioides immitis isolated during cluster investigation. Emerg Infect Dis. 2011 Feb
Stevens DA, Clemons KV, Levine HB et al. Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis 2009; 49:919-23
Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizonza. Ann NY Acad Sci 2007; 1111: 96-102.
Barker BM, Jewell KA, Kroken S, Orbach MJ. The population biology of Coccidioides: epidemiologic implications for disease outbreaks. Ann NY Acad Sci 2007; 1111: 147-63.
Valdivia L, Nix, D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis 2006; 12: 958-62.
Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41: 1217-23.
Park BJ, Sigel K, Vaz V, Komatsu K, McRill C, Phelan M, Colman T, Comrie AC, Warnock DW, Galgiani JN, Hajjeh RA, An epidemic of coccidioidomycosis in Arizona associated with climate changes, 1998-2001. J Infect Dis 2005; 191: 1981-7.
Cole GT, XUE CN, Okeke EJ, et al. A vaccine against coccidioidomycosis is justified and attainable. Medical Mycology 2004; 42: 189-216
Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am 2003; 17: 41-57.
Panackal AA, Hajjeh RA, Cetron MS, et al. Fungal infections among returning travelers. Clin Infect Dis 2002; 35: 1088-1095.
Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32: 708-715.
Leake JAD, Mosley DG England B, et al. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis 2000; 181: 1435-1440.
Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 2000; 181: 1428-1434.
Galgiani JN. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med 1999; 130: 293-300.
Ampel NM, Mosley DG, England B, et al. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis 1998; 27: 1528-1530.
Tsang, CA, Anderson, SM, Imholte, SB, Erhart, LM, & Chem, S. et al. (2010). Enhanced surveillance of coccidioidomycosis, arizona, usa 2007-2008. Emerging Infectious Diseases, 16(11), 1738-44.
Dodge, RR, Lebowitz, MD, Barbee, R, & Burrows, B. (1985). Estimates of c. immitis infection by skin test reactivity in an endemic community. American Journal of Public Health, 75(8), 863-865.
Kirkland, TN, & Fierer, J. (1996). Coccidioidomycosis: a reemerging infectious disease. Emerging Infectious Diseases, 3(2).
Oldfield, EC, Bone, WD, Martin, CR, Gray, GC, & Olson, P. (1997). Prediction of relapse after treatment of ciccidioidomycosis. Clinical Infectious Diseases, 25, 1205-1210.
Other Resources:
Information on Coccidioidomycosis for travelers from the CDC's Travelers' Health Yellow Book.
The University of Arizona —Valley Fever Center for Excellence—Coccidioidomycosis
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO



